9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Mesothelioma (MPM)

Estimated Enrollment: 27

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Recruiting

Study Results: No Results Available

Outcome Measures: Overall response rate,  ,  ,

Interventions: Avelumab, Stereotactic Body Radiation Therapy

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: December 2020

Completion Date: December 2020

Last  Posted Date: April 8, 2019

Location: Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States

Website Link: https://ClinicalTrials.gov/show/NCT03399552

Was this article helpful?
Dislike 0